1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > Asia-Pacific In-Vitro Fertilization Services Market - Opportunities and Forecasts, 2014 - 2020

In-vitro fertilization is an assisted reproductive technology, which involves a series of procedures for treating infertility problems. It involves the fertilization of the ovum in-vitro, followed by implantation of the embryo into a womens uterus. The IVF technology is fast gaining pace in the Asia Pacific region, as the infertility rates are spiraling. In addition, the rapidly rising geriatric population is a major concern for countries with below average birth rates such as, Indonesia, Vietnam, Cambodia and Philippines. Also, the rising trends towards delaying pregnancy has steadily increased in China and many other countries, resulting in aging of the eggs, making it less suitable for fertilization. This in turn, has increased the need of IVF services. Moreover, the commercialization of cost-effective fertility treatments and significant growth in medical tourism across Asia-Pacific would offer lucrative opportunities in future. Furthermore, proactive initiatives for the development of novel IVF technologies would facilitate the dynamic growth of the Asia-Pacific IVF market.The Asia-Pacific IVF services market was evaluated at $1.9 billion in 2014 and is estimated to garner $3.5 billion by 2020, registering a CAGR of 10.8% during the forecast period 20152020. This market is expected to witness significant growth during the forecast period on account of the delayed pregnancies, rising infertility rates due to dysfunctional lifestyles, environmental pollution, increasing disposable incomes and emergence of newer fertility tourism destinations. In addition, several academic institutions are collaborating with fertility hospitals and clinics to conduct extensive research & development activities, and provide more effective and better treatment facilities. The other factors, namely technological advancements, utilization of intra-cytoplasmic sperm injection (ICSI) technique and growing popularity of donor egg IVF methods would collectively boost the success rates of IVF cycles. However, factors such as high costs associated with the treatment, lack of favorable IVF reimbursement policies and lower health awareness, especially in the underdeveloped Asia-Pacific countries, such as Nepal and Myanmar, are the major factors hampering the market growth. In addition, ethical concerns regarding the parental rights are expected to have a restraining effect on the growth of the market.The Asia-Pacific IVF services market is segmented on the basis of end users, cycles type and country-wise analysis. Based on the type of cycle performed, the market is categorized into fresh cycle (non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycles. Fresh IVF cycle is the largest revenue-generating segment, owing to increasing preference of IVF for infertility treatment. The end users market is categorized into fertility clinics, hospitals, surgical centers and clinical research institutes. In 2014, fertility clinics were the leading end user segments, accounting for about one-fifths of the overall market share.Geographically, this market is segmented into India, China, Japan, Vietnam, Korea, Australia, New Zealand, Thailand, Malaysia, Indonesia, Philippines, Singapore, and other Asia-Pacific countries. In terms of revenue, Japan dominates the Asia-Pacific IVF market, owing to the large consumer base, rapid adoption of advanced technologies and availability of skilled workforce. However, the Indian IVF market is anticipated to register a promising CAGR of 14.7% during the forecast period. This is mainly supplemented by factors, such as the rising trend of fertility tourism, favorable regulation of surrogacy and donor services, and wide availability of IVF clinics. Based on number of cycles performed, Japan is the leading country, accounting for a major share of the market and is expected to maintain this trend throughout the forecast period. However, the India IVF market, in terms of number of cycles performed, is anticipated to grow at a promising CAGR of 16.3% during the study period.KEY MARKET BENEFITS:This report provides an in-depth analysis of the Asia-Pacific IVF market across seven major countries along with cross sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.It includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the Asia-Pacific IVF market.This report comprehensively analyzes the market scenario across different countries in the Asia-Pacific region.The projections in this report are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2014 to 2020.Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.ASIA-PACIFIC IN-VITRO FERTILIZATION SERVICES MARKET KEY SEGMENTS:The Asia-Pacific IVF market is segmented on the basis of end users, cycle type and country:By End Users (Value and Volume)Fertility clinicsHospitalsSurgical centersClinical research institutesBy Cycle Type, (Value and Volume)Fresh cycle (non-donor)Thawed IVF cycle (non-donor)Donor egg IVF cyclesBy Cycle Type Country Level Analysis (Value and Volume)IndiaChinaJapanAustraliaNew ZealandKoreaThailandSingaporeMalaysiaIndonesiaPhilippinesVietnamOthers

Table Of Contents

Asia-Pacific In-Vitro Fertilization Services Market - Opportunities and Forecasts, 2014 - 2020
CHAPTER 1 INTRODUCTION1.1 Report description1.2 Key benefits1.3 Coverage and limitations1.4 Research methodology1.4.1 Secondary research1.4.2 Primary research1.4.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARYCHAPTER 3 ASIA PACIFIC IVF MARKET ANALYSIS3.1 Market definition and scope3.2 Overview3.3 Drivers3.3.1 Delay in family planning reduces fertility3.3.2 Decline in birth rate3.3.3 Emotional problems3.4 Restraints3.5 Asia Pacific embryo transfer market by country3.6 Asia-Pacific fresh embryo transfersanddash;by country3.7 Asia-Pacific frozen embryo transfers by country3.8 Asia Pacific embryo transfer market by end users3.1 Asia-Pacific embryo transfer market by cycle type3.2 Company profile3.2.1 Thermo Fisher Scientific Inc.3.2.2 EMD Serono, Inc.CHAPTER 4 CHINA EMBRYO TRANSFER MARKET4.1 China embryo transfer market by end users4.2 China embryo transfer market by cycle type4.3 Drivers4.3.1 Increased rate of infertility4.3.2 Change in lifestyle4.4 Restraints4.4.1 Cost of living4.5 Regulatory issues, legislations and authorities4.6 Insurance reimbursement scenario4.7 Company profile4.7.1 Cook Medical, Inc.4.7.2 Vitrolife AB4.7.3 Centre for Reproductive Medicine4.7.4 Reproductive and genetic Hospital Citic-Xiangya4.7.5 Shenyang Hospital4.7.6 Shandong Provincial HospitalCHAPTER 5 INDIA EMBRYO TRANSFER MARKET5.1 India embryo transfer market by end users5.2 India embryo transfer market by cycle type5.3 Drivers5.4 Restraints5.5 Regulatory issues, legislations and authorities5.6 Insurance reimbursement scenario5.7 Company profile5.7.1 Sun Pharmaceutical Industries Ltd.5.7.2 Trivector Origio Scientific Pvt. Ltd5.7.3 Lab IVF Asia Pte. Ltd.5.7.4 LG Life Sciences.5.7.5 Cadila Healthcare Ltd. (Zydus Cadila group)5.7.6 Bourn Hall Clinic5.7.7 Morpheus IVF Fertility Center5.7.8 Southend Fertility and IVF Centre5.7.9 Nova IVI Fertility5.7.10 Bloom Fertility Center5.7.11 Manipal Ankur5.7.12 CloudnineCHAPTER 6 KOREA EMBRYO TRANSFER MARKET6.1 Korea embryo transfer market by end users6.2 Korea embryo transfer market by cycle type6.3 Drivers6.4 Restraints6.5 Regulatory issues, legislations and authorities6.6 Insurance reimbursement scenario6.7 Company Profiles6.7.1 Cha General Hospital6.7.2 Maria Fertility HospitalCHAPTER 7 NEW ZEALAND EMBRYO TRANSFER MARKET7.1 New Zealand embryo transfer market by end users7.2 New Zealand embryo transfer market by cycle type7.3 Drivers7.4 Restraints7.5 Regulatory issues, legislations and authorities7.6 Insurance reimbursement scenario7.7 Company Profiles7.7.1 Fertility Associates7.7.2 Fertility Plus7.7.3 ReporomedCHAPTER 8 AUSTRALIA EMBRYO TRANSFER MARKET8.1 Australia embryo transfer market by end users8.2 Australia embryo transfer market by cycle type8.3 Drivers8.4 Restraints8.4.1 Emotional and physical stress8.4.2 No guarantee8.4.3 Surplus embryos8.5 Regulatory issues, legislations and authorities8.5.1 Common Law8.5.2 Legislative responses to IVF8.5.3 Non-legislative regulation for the practice of IVF8.6 Insurance reimbursement scenario8.7 Company profile8.7.1 Genea Biomedx8.7.2 Thermo Fisher Scientific Inc.8.7.3 Virtus Health8.7.4 Monash IVF8.7.5 City Fertility8.7.6 Flinders FertilityCHAPTER 9 JAPAN EMBRYO TRANSFER MARKET9.1 Japan embryo transfer market by end users9.2 Japan embryo transfer market by cycle type9.3 Drivers9.4 Restraints9.5 Regulatory issues, legislations and authorities9.6 Insurance reimbursement scenario9.7 Company profile9.7.1 EMD Serono, Inc.9.7.2 IVF Namba Clinic9.7.3 Iwaki Womenandrsquo;s Clinic9.7.4 Sanno HospitalCHAPTER 10 SOUTH-EAST ASIA EMBRYO TRANSFER MARKET10.1 South-East Asia embryo transfer market10.2 Singapore embryo transfer market10.2.1 Singapore embryo transfer market by end users10.2.2 Singapore embryo transfer market by cycle type10.2.3 Drivers10.2.3.1 Government funding and tax rebates for parents10.2.3.2 Rising infertility rate10.2.3.3 Increase in success rate10.2.4 Restraints10.2.4.1 High cost of IVF treatment and lower success rate10.2.5 Regulatory issues, legislations and authorities10.2.6 Insurance reimbursement scenario10.2.7 Company profile10.2.7.1 Irvine Scientific10.2.7.2 Esco Technologies, Inc.10.2.7.3 Leica Microsystems Gmbh10.2.8 Company snapshot10.2.8.1 NUH IVF Centre10.2.8.2 Mount Elizabeth Fertility Center10.2.8.3 Thomson Fertility Centre10.2.8.4 Raffles Fertility Centre10.3 Malaysia embryo transfer market10.3.1 Malaysia embryo transfer market by end users10.3.2 Malaysia embryo transfer market by cycle type10.3.3 Drivers10.3.3.1 Increase in government initiatives10.3.3.2 Increase in the number of foreign patients10.3.3.3 Decrease in rate of fertility and growing acceptability of IVF10.3.4 Restraints10.3.5 Regulatory issues, legislations and authorities10.3.6 Insurance reimbursement scenario10.3.7 Company Profiles10.3.7.1 Subang Fertility Center Subang Jaya Hospital, Subang10.3.7.2 Concept Fertility Center10.3.7.3 TMC Fertility Center10.4 Indonesia embryo transfer market10.4.1 Indonesia embryo transfer market by end users10.4.2 Indonesia embryo transfer market by cycle type10.4.3 Drivers10.4.3.1 Increase in disposable income10.4.3.2 Advances in embryo transfer technology10.4.3.3 Decline in fertility rate10.4.4 Restraints10.4.4.1 Physical and emotional impact due to low success rate10.4.5 Regulatory issues, legislations and authorities10.4.6 Insurance reimbursement scenario10.4.7 Company profiles10.4.7.1 Morula IVF10.4.7.2 Yasmin IVF10.4.7.3 Aster Fertility Clinic10.4.7.4 Fertility Centre, Siloam Hospitals Surabana10.5 Philippines embryo transfer market10.5.1 Philippines embryo transfer market by end users10.5.2 Philippines embryo transfer market by cycle type10.5.3 Drivers10.5.3.1 Improve the replacement population10.5.3.2 Advancement in technology10.5.4 Restraints of embryo transfer market in Philippines10.5.5 Regulatory issues, legislations and authorities10.5.6 Insurance reimbursement scenario10.5.7 Company Profiles10.5.7.1 Victory Art Lab10.5.7.2 CRM-MIA-Philippines10.6 Thailand embryo transfer market10.6.1 Thailand embryo transfer market by end users10.6.2 Thailand embryo transfer market by cycle type10.6.3 Drivers10.6.3.1 Government initiatives10.6.3.2 Surrogacy is economical as compared to developed countries10.6.3.3 Boost in medical tourism10.6.4 Restraints of embryo transfer in Thailand10.6.4.1 Comparatively low success rate10.6.4.2 Ethical issues in allowing gender selection10.6.5 Regulatory issues, legislations and authorities10.6.6 Insurance reimbursement scenario10.6.7 Company Profiles10.6.7.1 Bangkok Fertility Center10.6.7.2 Siriraj Hospital10.6.7.3 Ramathibodi Hospital10.6.7.4 Perfect Woman Institute Piyavate Hospital10.6.7.5 Jetanin Institute for Assisted Reproduction10.7 Vietnam embryo transfer market10.7.1 Vietnam embryo transfer market by end users10.7.2 Vietnam embryo transfer market by cycle type10.7.3 Drivers10.7.3.1 Decline in fertility rate10.7.3.2 Reasonable cost and good success rate10.7.4 Restraints of the embryo transfer market in Vietnam10.7.5 Regulatory issues, legislations and authorities10.7.6 Insurance reimbursement scenario10.7.7 Company Profiles10.7.7.1 IVF Lab Tu Du Hospital Vietnam10.7.7.2 IVF Van Hanh10.7.7.3 IVFAS10.7.7.4 Tu Du - Ho Chi Minh City Vietnam10.8 Others embryo transfer market10.8.1 Others embryo transfer market by end usersList of FiguresFIG. 1 PERCENTAGE OF PEOPLE WHO PERCEIVED VARIOUS INFERTILITY REASONS (SINGAPORE, THAILAND, INDONESIA AND CHINA)FIG. 2 CHINA FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)FIG. 3 INDIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)FIG. 4 SOUTH KOREA TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)FIG. 5 NEW ZEALAND TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)FIG. 6 AUSTRALIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)FIG. 7 JAPAN TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)FIG. 8 SINGAPORE FERTILITY RATE CHILD BORN/WOMEN (2010-2014)FIG. 9 MALAYSIA FERTILITY RATE CHILD BORN/WOMEN (2010-2014)FIG. 10 INDONESIA FERTILITY RATE CHILD BORN/WOMEN (2010-2014)FIG. 11 PHILIPPINES FERTILITY RATE CHILD BORN/WOMEN (2014-2020)FIG. 12 THAILAND FERTILITY RATE CHILD BORN/WOMEN (2014-2020)FIG. 13 VIETNAM FERTILITY RATE CHILD BORN/WOMEN (2014-2020)List of TablesTABLE 1 ASIA PACIFIC IVF CYCLES MARKET VOLUME, BY COUNTRY, 2014 anddash; 2020 (THOUSAND)TABLE 2 ASIA PACIFIC EMBRYO TRANSFER MARKET VOLUME, BY COUNTRY, 2014 anddash; 2020 (THOUSAND)TABLE 3 ASIA PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY COUNTRY, 2014 anddash; 2020 ($MILLION)TABLE 4 ASIA-PACIFIC FRESH EMBRYO TRANSFER MARKET VOLUME, BY COUNTRY, 2014 anddash; 2020 (THOUSAND)TABLE 5 ASIA-PACIFIC FRESH EMBRYO TRANSFER MARKET REVENUE, BY COUNTRY, 2014 anddash; 2020 ($MILLION)TABLE 6 ASIA-PACIFIC FROZEN EMBRYO TRANSFER MARKET VOLUME, BY COUNTRY, 2014 anddash; 2020 (THOUSAND)TABLE 7 ASIA-PACIFIC FROZEN EMBRYO TRANSFER MARKET REVENUE, BY COUNTRY, 2014 anddash; 2020 ($MILLION)TABLE 8 ASIA PACIFIC EMBRYO TRANSFER MARKET VOLUME, BY END USER, 2014 anddash; 2020 (THOUSAND)TABLE 9 ASIA PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY END USER, 2014 anddash; 2020 ($MILLION)TABLE 10 ASIA-PACIFIC EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014-2020 (THOUSAND)TABLE 11 ASIA-PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014-2020 ($MILLION)TABLE 12 THERMO FISHER SCIENTIFIC INC. BUSINESS OVERVIEWTABLE 13 COMPANY SNAPSHOTTABLE 14 EMD SERONO INC BUSINESS OVERVIEWTABLE 15 COMPANY SNAPSHOTTABLE 16 CHINA EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 17 CHINA EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 18 CHINA EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 19 CHINA EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 20 COOK MEDICAL INC BUSINESS OVERVIEWTABLE 21 COMPANY SNAPSHOTTABLE 22 VITROLIFE AB INC BUSINESS OVERVIEWTABLE 23 COMPANY SNAPSHOTTABLE 24 INDIA EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 25 INDIA EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 26 INDIA EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 27 INDIA EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 28 SUN PHARMACEUTICAL BUSINESS OVERVIEWTABLE 29 COMPANY SNAPSHOTTABLE 30 TRIVECTOR ORIGIO SCIENTIFIC BUSINESS OVERVIEWTABLE 31 COMPANY SNAPSHOTTABLE 32 LAB IVF ASIA BUSINESS OVERVIEWTABLE 33 COMPANY SNAPSHOTTABLE 34 LG LIFE SCIENCE BUSINESS OVERVIEWTABLE 35 COMPANY SNAPSHOTTABLE 36 CADILA HEALTH CARE BUSINESS OVERVIEWTABLE 37 COMPANY SNAPSHOTTABLE 38 KOREA EMBRYO TRANSFER MARKET VOLUME, BY END USER, 2014-2020 (THOUSAND)TABLE 39 KOREA EMBRYO TRANSFER MARKET REVENUE, BY END USER, 2014-2020 ($MILLION)TABLE 40 KOREA EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014-2020 (THOUSAND)TABLE 41 KOREA EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014-2020 ($MILLION)TABLE 42 NEW ZEALAND EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 43 NEW ZEALAND EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 44 NEW ZEALAND EMBRYO TRANSFER MARKET, BY CYCLE TYPE, 2014-2020 ($MILLION)TABLE 45 NEW ZEALAND EMBRYO TRANSFER MARKET, BY CYCLE TYPE, 2014-2020 (THOUSAND)TABLE 46 AUSTRALIA EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 47 AUSTRALIA EMBRYO TRANSFERS MARKET REVENUE BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 48 AUSTRALIA EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014-2020 (THOUSAND)TABLE 49 AUSTRALIA EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014-2020 ($MILLION)TABLE 50 GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEWTABLE 51 COMPANY SNAPSHOTTABLE 52 THERMO FISHER SCIENTIFIC INC BUSINESS OVERVIEWTABLE 53 COMPANY SNAPSHOTTABLE 54 JAPAN EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 55 JAPAN EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 56 JAPAN EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 57 JAPAN EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 58 EMD SERONO INC BUSINESS OVERVIEWTABLE 59 COMPANY SNAPSHOTTABLE 60 TOTAL FERTILITY RATE OF SOUTH-EAST ASIA COUNTRY PER THOUSAND, 2015TABLE 61 SOUTH-EAST ASIA EMBRYO TRANSFER MARKET VOLUME, BY COUNTRY, 2014 anddash; 2020 (THOUSAND)TABLE 62 SOUTH-EAST ASIA EMBRYO TRANSFER MARKET REVENUE, BY COUNTRY, 2014 anddash; 2020 ($MILLION)TABLE 63 SINGAPORE EMBRYO TRANSFER MARKET VOLUME, BY END USER, 2014 anddash; 2020 (THOUSAND)TABLE 64 SINGAPORE EMBRYO TRANSFER MARKET REVENUE, BY END USER, 2014 anddash; 2020 ($MILLION)TABLE 65 SINGAPORE EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 66 SINGAPORE EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 67 IRVINE SCIENTIFIC BUSINESS OVERVIEWTABLE 68 COMPANY SNAPSHOTTABLE 69 ESCO TECHNOLOGIES BUSINESS OVERVIEWTABLE 70 COMPANY SNAPSHOTTABLE 71 LEICA MICROSYSTEMS GMBH BUSINESS OVERVIEWTABLE 72 MALAYSIA EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 73 MALAYSIA EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 74 MALAYSIA EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 75 MALAYSIA EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 76 INDONESIA EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 77 INDONESIA EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 78 INDONESIA EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 79 INDONESIA EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 80 PHILIPPINES EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 81 PHILIPPINES EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 82 PHILIPPINES EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 83 PHILIPPINES EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 84 THAILAND EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 85 THAILAND EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 86 THAILAND EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 87 THAILAND EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 88 VIETNAM EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014 anddash; 2020 (THOUSAND)TABLE 89 VIETNAM EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014 anddash; 2020 ($MILLION)TABLE 90 VIETNAM EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014 anddash; 2020 (THOUSAND)TABLE 91 VIETNAM EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014 anddash; 2020 ($MILLION)TABLE 92 OTHERS EMBRYO TRANSFER MARKET VOLUME, BY END USERS, 2014-2020 (THOUSAND)TABLE 93 OTHERS EMBRYO TRANSFER MARKET REVENUE, BY END USERS, 2014-2020 ($MILLION)TABLE 94 EMBRYO TRANSFER COST PER CYCLE BY COUNTRY (2014)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.